Edgewise Therapeutics, Inc.
USD41.46
-0.23 (-0.55%)
CEO
Kevin Koch
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$41.08
Prev. Close
$41.69
Day Low
$40.31
Day High
$42.81
52W Low
$12.30
52W High
$43.93
Market Cap
$4.46B
Volume
2.48M
| 16,377 |
| $35.59 |
| 17 Jun 2026 | Morris Arlene | director | A-Award | Acquired | 16,377 | $35.59 |
| 16 Jun 2026 | Edris Badreddin | director | A-Award | Acquired | 5,619 | $0.00 |
| 16 Jun 2026 | Edris Badreddin | director | A-Award | Acquired | 8,188 | $35.59 |
| 16 Jun 2026 | Martin Christopher Nathan | director | A-Award | Acquired | 16,377 | $35.59 |
| 16 Jun 2026 | Fox Jonathan C | director | A-Award | Acquired | 16,377 | $35.59 |
| 5 May 2026 | Donovan Joanne M. | CMO | S-Sale | Disposed | 5,230 | $31.29 |
| 5 May 2026 | Donovan Joanne M. | CMO | M-Exempt | Acquired | 50,000 | $7.08 |
| 5 May 2026 | Donovan Joanne M. | CMO | S-Sale | Disposed | 50,000 | $38.57 |